Patents by Inventor Marcus Schittenhelm

Marcus Schittenhelm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASPP2 splicing variant
    Patent number: 9079938
    Abstract: The present invention relates to a method for the in vitro determination of the presence of or a predisposition of a patient to the development of cancer. In the method according to the invention, the presence of a marker is determined in a biological sample of the patient, said marker being selected from a) the amino acid sequence SEQ ID No. 2 from the sequence protocol that is provided, or b) a nucleic acid that encodes the amino acid sequence with the SEQ ID No. 2. The invention further relates to the amino acid and the encoding nucleic acid and to the use thereof in diagnostics and for molecular therapeutic approaches.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: July 14, 2015
    Assignee: Eberhard-Karls-Universität Tübingen Universitätsklinikum
    Inventors: Kerstin Kampa-Schittenhelm, Marcus Schittenhelm